Safety, pharmacokinetics, and preliminary assessment of efficacy of mecasermin (recombinant human IGF-1) for the treatment of Rett syndrome (Q30574939)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Safety, pharmacokinetics, and preliminary assessment of efficacy of mecasermin (recombinant human IGF-1) for the treatment of Rett syndrome
scientific article

    Statements

    Safety, pharmacokinetics, and preliminary assessment of efficacy of mecasermin (recombinant human IGF-1) for the treatment of Rett syndrome (English)
    Katherine V Barnes
    Heather M O'Leary
    Yaron Finkelstein
    Charles A Nelson
    Vanessa Vogel-Farley
    Geneva DeGregorio
    Umakanth Khatwa
    Mark E Alexander
    Deirdre M Finnegan
    Nicole G Cantwell
    Alexandra C Walco
    Leonard Rappaport
    Raina N Fichorova
    Michael W Shannon

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit